Program Materials Requirements
Front Cover
- Vegas Cosmetic Surgery
- June 10-12, 2021
- Bellagio Hotel & Casino + Livestream
- “This activity is jointly provided by Global Education Group and Informa Markets.”
- This activity is supported by educational grants from AbbVie, Galderma, Merz and Suneva.
- This activity is supported by educational, in-kind grants of neurotoxins, provided by AbbVie, Galderma and Merz.
- This activity is supported by educational, in-kind grants of dermal fillers, provided by AbbVie, Galderma, Merz, MTF Biologics, Prollenium and Revance.
- This activity is supported by educational, in-kind grants of deoxycholic acid, provided by AbbVie.
Target Audience
This activity has been designed to meet the educational needs of those Board Certified or Board Eligible in Plastic Surgery, Facial Plastic Surgery, Dermatology, and Oculoplastic Surgery, and Allied Health Professionals working directly with one of those specialists.
Statement of Need/Program Overview
Physicians and professional medical staff practicing aesthetic medicine need the educational tools to acquire the knowledge necessary for effective, safe and high-level patient care. The education of physicians and professional medical staff is essential to providing effective patient care in a medical aesthetic practice. There is a lack of educational conferences where physicians and their entire staff of medical professionals can attend together to learn the same information at the same time via didactic sessions.
Educational Objectives
• Assess the most current safety and efficacy data of facial injectable products
• List the mechanism of action of neurotoxin and dermal filler injections for individual patients
• Identify proper injection techniques that have demonstrated safe and satisfactory patient outcomes to minimize complications
• Identify complications resulting from surgical and/or nonsurgical procedures
• Differentiate the various approaches to oculoplastic surgery (blepharoplasty, eyebrow lifts, etc.) to determine the best suited procedure for individual patient
• Assess best practices for choosing which patients might be the best candidates for surgical rejuvenation
• Compare options for minimally invasive body shaping, contouring, fat reduction and cellulite treatment
• Differentiate between surgical options for rhinoplasty (open; closed; ethnic considerations, etc.) to determine the best suited procedure for individual patient
• Assess controversial topics in facial and body surgery
• Identify techniques and devices used in body shaping/contouring.
• Identify various approaches to facelifting and which procedure is appropriate for which patient
• Recall facial anatomy and associated structures (i.e. eyes, forehead, neck, etc) for nonsurgical rejuvenation
• Examine indications and treatment of photodamaged skin, including chemical peels, dermabrasion and topical therapies.
• Explain the benefits of available energy-based devices in aesthetic procedures.
• Identify appropriate techniques for hair removal procedures.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Informa Markets. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 16.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected]
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the posttest and evaluation. A link to do so will be emailed to you at the end of the meeting. If you have any questions, please contact Liddy Knight at [email protected]
System Requirements for Livestreaming
PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*
MAC
MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.
Fee Information& Refund/Cancellation Policy
There is a fee for this educational activity.
IN-PERSON REGISTRATION OPTIONS
Registration for the In-Person event will not be available on-site due to COVID restrictions,and will only be accepted until June 7th.
Physician / Advanced Provider (DNP, FNP-C, ARNP, PA, PA-C) / Clinical Staff (RN, LPN)*---------$1,350 $1,550
Practice Management Staff*------------------------------------------------------------------------$1,000 $1,150
Resident (valid proof of residency is required)------------------------------------------------------$495 $595
Industry (companies that sell products or services to the aesthetic medicine industry)------------$4,900 $4,900
LIVESTREAM REGISTRATION OPTIONS
General Admission
$495
Not available for Industry (companies that sell products or services to the aesthetic medicine industry).
Resident
$300
Valid proof of residency is required.
Cancellation Policy
For individual as for group registrations:
Cancellation must be notified in writing via email to: [email protected]
• Until 30 days before the Event: 20% processing fees on the total registration
• Between 30 to 15 days before the Event: 50% cancellation fees on the amount paid
• From 15 days before the Event date or no show: No refund – except in case of “force majeure”, conditions detailed below.
For the purpose of this cancellation policy, the relevant dates shall be fixed by reference to the originally scheduled opening date of the Event and not any newly scheduled opening date of the Event that has been changed as a result of the force Majeure conditions below.
“FORCE MAJEURE”
Refunds may be granted by the organizer, after evaluation, if the participant is unable to attend the event due to a severe accident, close relative illness (children, husband/spouse, brother/sister), or family death.Refunds may be granted by the organizer if it determines that the Event shall be cancelled or postponed due to an event of force majeure, or alternatively, the Organizer may, acting in its sole discretion, decide to transfer all registrations to the next scheduled edition of the Event.In all cases, refunds will be subject to a minimum deduction equal to 10% of the booking charges by way of a processing fees.
For any assistance in such circumstances, please contact us at [email protected]
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
| Name of Faculty or Presenter | Reported Financial Relationship |
|---|---|
| Sheila Barbarino, MD | "Consulting Fee (e.g., Advisory Board): Merz, Evolus, Suneva Contracted Research (Principal Investigators must provide information, even if received by the institution): Skinceuticals, Merz Honoraria: Merz, Skinceuticals" |
| Afzaal Bahir, MD | Nothing to disclose |
| Olga Borzykh, MD | Nothing to disclose |
| Amy Brodsky, MD | "Honoraria: Suneva Medical, Inc. Speakers' Bureau: Suneva Medical, Inc." |
| Vivian Bucay, MD | "Consultant/Independent Contractor: Rodan + Fields Speaker's Bureau: Galderma, SkinCeuticals, La Roche-Posay, Medicell Technologies Advisory Board: Aesthetics Biomedical, PCA Skin, Allergan Aesthetics, Senté, Ferndale" |
| John Burroughs, MD | Nothing to disclose |
| Benjamin Caughlin, MD | Nothing to disclose |
| Eric Cerrati, MD | Nothing to disclose |
| Joel Cohen, MD | "Consultant/Independent Contractor: Galderma, Revance, Merz, Allergan, BioPelle, Revision, Sente, PCA, Elta, Sciton, Lutronic, Pulse, BioFrontera Grant/Research Support: Pulse, Accure, Galderma, Merz, Revance, Recros, Brickell, Croma, InMode, BioFrontera Honoraria: Galderma, Sciton" |
| John Cook, MD | Nothing to disclose |
| Hasim Eray Copcu, MD | Nothing to disclose |
| Stella Desyatnikova, MD | Nothing to disclose |
| Arthur Diaz-Carandell, MD | Nothing to disclose |
| Barry Dibernardo, MD | "Consulting Fee (e.g., Advisory Board): Cynosure, Underskin, Cytrellis, Contracted Research (Principal Investigators must provide information, even if received by the institution): Apyx, BTL, Cynosure,Optigenix, Cytrellis, Implicicare, MTF , Sciton, Honoraria: Cynosure, Inmode, BTL, Speakers' Bureau: Cynosure, BTL ,Alma, Inmode, Sciton, Implicitcare, UnderSkin, Sofwave Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): RealSelf, Sciton, Implicitcare, Brijjit, Revance, RMI, sofwave" |
| Christian Drehsen, MD | Nothing to disclose |
| Diane Duncan, MD | Nothing to disclose |
| Kay Durairaj, MD | "Consulting Fee (e.g., Advisory Board): Merz, Allergan, Galderma, Evolus, Revance, Revanesse Contracted Research (Principal Investigators must provide information, even if received by the institution): Merz Honoraria: Merz, Allergan, Galderma, Evolus, Revance, Revanesse Speakers' Bureau: Merz, Galderma Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed):Revance" |
| Lisa Durette, MD | Nothing to disclose |
| Jason Emer, MD | Nothing to disclose |
| Richard Gentile, MD | "Consulting Fee (e.g., Advisory Board): Apyx Medical Honoraria: Apyx Medical, Solta Medical Speakers' Bureau: Apyx Medical, Solta Medical Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Apyx Medical" |
| Michael Gold, MD | Honoraria: Aerolase, Alastin, Allergan, Alma Lasers, Almirall, BioFrontera, Clarify MD, Croma, DefenAge, Dermira, EndyMed, Essence Novel, Galderma, Hugel, IntraDerm, Invasix / InMode, Johnson & Johnson, Joylux, Lumenis, Merz, MTF, NanoPass, Neauvia, Novartis, Pierre Fabre / Glytone, Revision, Sensus, Senté, Skinbetter Science, Sofregen, Stratpharma, Suneva, Candela, Viviscal, Zimmer, |
| Neil Gordon, MD | Nothing to disclose |
| Yael Halaas, MD | "Contracted Research (Principal Investigators must provide information, even if received by the institution): BTL Honoraria: Evolus, Kimera, Direct Biologics, Ctown, plasmaconcepts, BTL, Inmode Speakers' Bureau: Evolus, Kimera, Venus, Ctown, plasmaconcepts, BTL, Inmode Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Venus, Endo Aesthetics" |
| Chrstine Hamori, MD | Nothing to disclose |
| Andrew Harrison, MD | "Consulting Fee (e.g., Advisory Board): Horizon Pharmaceuticals, Osmotica/RVL pharmaceuticals Speakers' Bureau: Horizon pharmaceuticals Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): osmotica pharmaceuticals" |
| Midey Helmy, MD | Nothin to discole |
| Gary Horndeski, MD | Owner/Co-Owner Founder/Co-Founder: Innovellum |
| Elizabeth Houshmand, MD | Nothing to disclose |
| Ari Hyman, MD | Nothing to disclose |
| Sherrif Ibrahim, MD | "Contracted Research (Principal Investigators must provide information, even if received by the institution): Galderma Speakers' Bureau: Galderma Other (Describe): Sciton Strategic Advisory Board. I have not received direct payment but I have received reduced cost equipment." |
| Vitaliy Igumnov, MD | Nothing to disclose |
| Carolyn Jacob, MD | "Consulting Fee (e.g., Advisory Board): PCA, BTL Contracted Research (Principal Investigators must provide information, even if received by the institution): Galderma, Soiton, Endo pharmeceuticals, Alastin, BTL, PCA Honoraria: Abbvie, Galderma, BTL, PCA, Alastin Speakers' Bureau: Abbvie, Galderma, BTL, PCA, Alastin Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Alastin, Revance" |
| John Joseph, MD | "Consulting Fee (e.g., Advisory Board): Galderma, Merz, Endo Contracted Research (Principal Investigators must provide information, even if received by the institution): Allergan, Galderma, Merz, Revance, Croma, Evolus, Endo, Recros, Teoxane Honoraria: Galderma, Endo Speakers' Bureau: Galderma Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Evolus, Revance" |
| Jonathan Kaplan, MD | Owner/Co-Owner Founder/Co-Founder: KP Innovations LLC |
| Kian Karimi, MD | Owner/Co-Owner Founder/Co-Founder: CosmoFrance, Sutura, and HealMD |
| Khalil Khatri, MD | Nothing to disclose |
| Jennifer Levine, MD | Nothing to disclose |
| William Mack, MD | Nothing to disclose |
| Philip Miller, MD | Trainer: Allergan |
| Mohsen Naraghi, MD | Nothing to disclose |
| Melanie Palm, MD | "Consulting Fee (e.g., Advisory Board): Allergan, Galderma, Merz, Lumenis, BTL Contracted Research (Principal Investigators must provide information, even if received by the institution): Allergan, Galderma, Merz, Lumenis, BTL Honoraria: Allergan, Galderma, Merz, Lumenis, BTL Speakers' Bureau: Allergan, Galderma, Merz, Lumenis, BTL" |
| Sean Paul, MD | Consulting Fee (e.g., Advisory Board): InMode (trainer), MyEllevate (trainer) |
| Steven Pearlman, MD | Speakers' Bureau: Inmode |
| Christine Petti, MD | "Consulting Fee (e.g., Advisory Board): Cynosure Lasers, Inc, Cartessa Aesthetics, LLC Speakers' Bureau: Cynosure Lasers, Inc." |
| Alexander Rivkin, MD | "Consulting Fee (e.g., Advisory Board): Allergan, Galderma, Merz, Suneva, Revance, Evolus, Endo Contracted Research (Principal Investigators must provide information, even if received by the institution): Galderma, Allergan Honoraria: Allergan, Galderma, Merz, Suneva, Revance, Evolus, Endo Speakers' Bureau: Allergan, Galderma, Merz, Suneva, Revance, Evolus, Endo" |
| Deanne Robinson, MD | "Employee: Ideal Image Consulting Fee (e.g., Advisory Board): SkinBetter Science, Alastin, ISDIN, Allergan Aesthetics, Merz, Galderma, Endo Aesthetics Contracted Research (Principal Investigators must provide information, even if received by the institution): SkinBetter Science, Alastin, ISDIN, Allergan Aesthetics, Merz, Galderma, Endo Aesthetics Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Alastin" |
| Adam Rubinstein, MD | Speakers' Bureau: Apyx Medical |
| Renato Saltz, MD | "Consulting Fee (e.g., Advisory Board): ALLERGAN,SYMPLAST, ALASTIN, DOMINION AESTHETICS Royalty: QMP" |
| Robert Schwarcz, MD | Nothing to disclose |
| Falguni Shah, MD | Nothing to disclose |
| Jessica Shepherd, MD | Nothing to disclose |
| Robyn Siperstein, MD | "Consulting Fee (e.g., Advisory Board): Allergan, Galderma Contracted Research (Principal Investigators must provide information, even if received by the institution): Allergan, Galderma" |
| Candance Spann, MD | "Owner/Co-Owner Founder/Co-Founder: ReTress, LLC Consulting Fee (e.g., Advisory Board): PCA Skin Honoraria: PCA Skin, LaRoche Posay, Clarisonic" |
| Jessy Suryadi, MD | Nothing to disclose |
| Ben Talei, MD | Nothing to disclose |
| Elizabeth I. Tanzi, MD | "Consulting Fee (e.g., Advisory Board): Endo Pharmaceuticals, Soliton, Allergan/Coolsculpting, Pulse Biosciences, Sciton, Alastin, Beiersdorf Contracted Research (Principal Investigators must provide information, even if received by the institution): Soliton, Pulse BioSciences" |
| Gregory Vipond, MD | Nothing to disclose |
| Jennifer Weyler, MD | Nothing to disclose |
| Kateryn Perez Willis, MD | Nothing to disclose |
| Jackie Yee, MD | "Consulting Fee (e.g., Advisory Board): Allergan, Endo Aesthetics, Evolus, Galderma Laboratories, Revance Therapeutics, SAI MedPartners LLC Honoraria: Allergan, Endo Aesthetics, Evolus, Galderma Laboratories, Medical Education Advocates LLC, Revance Therapeutics, X-Medica, Speakers' Bureau: Allergan, Endo Aesthetics, Galderma Laboratories, Medical Education Advocates LLC, Revance, X-Medica" |
| Arthur Yu, MD | Nothing to disclose |
| Chad Zatezalo, MD | Nothing to disclose |
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter
Ashley Marostica, RN, MSN
Reported Financial Relationship
Nothing to disclose
Lindsay Borvansky
Nothing to disclose
Andrea Funk
Nothing to disclose
Liddy Knight
Nothing to disclose
Ashley Cann
Nothing to disclose
Tawni Bosiljevac
Nothing to disclose
Erin Velardo
Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Informa Markets do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.